Mumbai: Thanks to stem cell therapy a 24-year-old engineering student who was crippled due to Multiple Sclerosis has started to walk again.
Sushant Chavan was diagnosed with Multiple Sclerosis in October 2011. Though he initiated medical treatment, Chavan’s condition deteriorated within two years and he lost his speech and even urinary control.
He was treated by Pradeep Mahajan, a city-based expert in stem cell therapy.
According to Mahajan, Chavan’s condition had deterioriated to such an extent that medicines were not making any positive effect due to the late diagnosis of the disease. Hence, he was given the stem cell therapy in different sessions with a proper time gap.
Exposure to paint, varnish and other solvents may put people at a 50 per cent higher risk of developing multiple sclerosis (MS), a potentially disabling disease affecting the central nervous system, a study says.
With exposure to solvents, people who also carry genes that make them more susceptible to developing multiple sclerosis are nearly seven times as likely to develop the disease as compared to those with no solvent exposure who do not carry the MS genes, said the study published in the journal Neurology.
For people who have been smokers, the risk is even greater. Those who have been smokers with solvent exposure and the MS genes are 30 times more likely to develop MS than those who have never smoked or been exposed to solvents and who do not have the genetic risk factors, said the study.
“These are significant interactions where the factors have a much greater effect in combination than they do on their own,” said study author Anna Hedstrom from the Karolinska Institutet in Stockholm, Sweden.
“It’s possible that exposure to solvents and smoking may both involve lung inflammation and irritation that leads to an immune reaction in the lungs,” Hedstrom added.
For the study, the researchers identified 2,042 people who had recently been diagnosed with MS and matched them with 2,947 people of the same age and sex.
Blood tests were used to determine whether the participants had two human leukocyte antigen gene variants — one of which makes people more likely to develop MS and the other reduces the risk.